The Patent Finder

Terms ending in 2034

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US D838,840Injector Device
In force
 · High confidence
AbbVie Biotechnology Ltd. (Puerto Rico Branch)In forceHigh confidence
US D839,584Medication Packaging and Dispensing System
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,184,003Prolactin Receptor Binding Proteins and Uses Thereof
In force
 · Medium confidence
AbbVie Inc.In forceMedium confidence
US 10,081,628Apoptosis-Inducing Agents for the Treatment of Cancer and Immune and Autoimmune Diseases
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,655,964Bispecific Antibodies Directed Against Tnf-A and IL-17
In force
 · Medium confidence
AbbVie Inc.In forceMedium confidence
US 8,980,879Bromodomain Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,050,346Bromodomain Inhibitors
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 8,921,526MUTATED ANTI-TNFa ANTIBODIES AND METHODS OF THEIR USE
In force
 · High confidence
AbbVie, Inc.In forceHigh confidence
US 9,006,438Processes For The Preparation Of An Apoptosis-Inducing Agent
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,199,992Processes for the Preparation of an Apoptosis-Inducing Agent
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
37 more term ends in 2034 · Pro
10 of 47 patents shown. Soonest term end first, then patent number.
Pro members see all 47.
Upgrade to Pro
43 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited